147 related articles for article (PubMed ID: 2900146)
1. Haemodynamic effects of short-term treatment with bopindolol in essential hypertension.
Fitscha P; Meisner W; Brandstetter G; Tiso B
Eur J Clin Pharmacol; 1988; 34(4):411-3. PubMed ID: 2900146
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the acute haemodynamic effects of bopindolol and propranolol at rest and during supine exercise.
Fitscha P; Meisner W; Tiso B
Eur J Clin Pharmacol; 1988; 34(4):359-62. PubMed ID: 2900143
[TBL] [Abstract][Full Text] [Related]
4. The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension.
van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Derkx FH; Mulder P; Schalekamp MA
Clin Pharmacol Ther; 1987 Oct; 42(4):411-9. PubMed ID: 2889554
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers.
Nieminen MS; Rapola J; Pellinen TJ; Toivonen L
Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879
[TBL] [Abstract][Full Text] [Related]
6. Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.
Atterhög JH; Dunér H; Pernow B
Am J Med; 1976 May; 60(6):872-6. PubMed ID: 14501
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive treatment with bopindolol alone or combined with a diuretic in general practice.
Weidmann P; Bousquet JC
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S80-7. PubMed ID: 2439828
[TBL] [Abstract][Full Text] [Related]
8. Effect of bopindolol on the circadian blood pressure profile in essential hypertension.
Favre L; Adamec R; Boxho G
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S60-3. PubMed ID: 2439823
[TBL] [Abstract][Full Text] [Related]
9. Effects of bopindolol on left ventricular function during exercise in patients with coronary artery disease.
Righetti A; Mérier G; Viquerat C; Ratib O; Rutishauser W
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S39-41. PubMed ID: 2439817
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effect of pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
Atterhög JH; Dunér H; Pernow B
Acta Med Scand; 1976; 199(4):251-5. PubMed ID: 1266662
[TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.
Schiess W; Welzel D; Gugler R
Eur J Clin Pharmacol; 1984; 27(5):529-34. PubMed ID: 6151506
[TBL] [Abstract][Full Text] [Related]
13. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
Ishibashi T; Mitomi A; Tatebe S; Imai S
Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive efficacy of the new long-acting beta-blocker bopindolol as related to age.
Hulthén UL; van Brummelen P; Amann FW; Bühler FR
J Cardiovasc Pharmacol; 1983; 5(3):426-9. PubMed ID: 6191141
[TBL] [Abstract][Full Text] [Related]
15. Acute and long-term antihypertensive effect of bopindolol--a nonselective beta-adrenergic blocker with ISA.
Andersson OK; Hedner T; Nyberg G
Eur J Clin Pharmacol; 1985; 29(3):281-5. PubMed ID: 2866965
[TBL] [Abstract][Full Text] [Related]
16. Dose-finding study with bopindolol in arterial hypertension.
Willimann P; Peter R; Siegenthaler H
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic effects of beta-receptor blockade during acute administration and chronic treatment.
Jensen HA
Acta Med Scand Suppl; 1982; 665():79-81. PubMed ID: 6130678
[TBL] [Abstract][Full Text] [Related]
19. [Antihypertensive effect of bopindolol on stroke-prone spontaneously hypertensive rats (SHRSP)].
Yamashita K; Shigematsu K; Maeda T; Ishida Y; Niwa M; Ozaki M
Nihon Yakurigaku Zasshi; 1989 Jan; 93(1):7-15. PubMed ID: 2565861
[TBL] [Abstract][Full Text] [Related]
20. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
Honorato J; Galende I; Catalán M; Azanza JR
Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
